Publikationen in Zusammenarbeit mit Forschern von University of Cagliari (80)

2024

  1. A New Class of Benzo[b]thiophene-chalcones as Cholinesterase Inhibitors: Synthesis, Biological Evaluation, Molecular Docking and ADME Studies

    Molecules , Vol. 29, Núm. 16

2023

  1. 2H-chromene and 7H-furo-chromene derivatives selectively inhibit tumour associated human carbonic anhydrase IX and XII isoforms

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 38, Núm. 1

  2. Design of 3-Phenylcoumarins and 3-Thienylcoumarins as Potent Xanthine Oxidase Inhibitors: Synthesis, Biological Evaluation, and Docking Studies

    ChemMedChem, Vol. 18, Núm. 21

  3. Villoglandular Pattern in HPV-associated Endocervical Adenocarcinoma is Associated with Excellent Prognosis: A Reappraisal of 31 Cases Using IECC and Silva Pattern Classification

    International Journal of Gynecological Pathology, Vol. 42, Núm. 3, pp. 270-277

2022

  1. Clear Cell Carcinoma (CCC) of the Cervix Is a Human Papillomavirus (HPV)-independent Tumor Associated With Poor Outcome A Comprehensive Analysis of 58 Cases

    American Journal of Surgical Pathology, Vol. 46, Núm. 6, pp. 765-773

  2. Coumarin-Resveratrol-Inspired Hybrids as Monoamine Oxidase B Inhibitors: 3-Phenylcoumarin versus trans-6-Styrylcoumarin

    Molecules, Vol. 27, Núm. 3

  3. Hydroxy-3-Phenylcoumarins as Multitarget Compounds for Skin Aging Diseases: Synthesis, Molecular Docking and Tyrosinase, Elastase, Collagenase and Hyaluronidase Inhibition, and Sun Protection Factor

    Molecules, Vol. 27, Núm. 20

  4. Structural Insight of New Butyrylcholinesterase Inhibitors Based on Benzylbenzofuran Scaffold

    Pharmaceuticals, Vol. 15, Núm. 3

2021

  1. Gamma-decanolactone: Preliminary evaluation as potential antiparkinsonian drug

    European Journal of Pharmacology, Vol. 906

  2. Synthesis and in vitro study of nitro- and methoxy-2-phenylbenzofurans as human monoamine oxidase inhibitors

    Bioorganic Chemistry, Vol. 107

2020

  1. Broad Spectrum project: Factors determining the quality of antibiotic use in primary care: An observational study protocol from Italy

    BMJ Open, Vol. 10, Núm. 7

  2. Looking for new xanthine oxidase inhibitors: 3-Phenylcoumarins versus 2-phenylbenzofurans

    International Journal of Biological Macromolecules, Vol. 162, pp. 774-780

  3. Structure-Based Optimization of Coumarin hA3 Adenosine Receptor Antagonists

    Journal of Medicinal Chemistry, Vol. 63, Núm. 5, pp. 2577-2587

2019

  1. Antibacterial Activity and Molecular Docking Studies of a Selected Series of Hydroxy-3-arylcoumarins

    Molecules (Basel, Switzerland), Vol. 24, Núm. 15

  2. Discovery of new phthalazinones as vasodilator agents and novel pharmacological tools to study calcium channels

    Future Medicinal Chemistry, Vol. 11, Núm. 3, pp. 179-191

  3. Synthesis, molecular docking and cholinesterase inhibitory activity of hydroxylated 2-phenylbenzofuran derivatives

    Bioorganic Chemistry, Vol. 84, pp. 302-308

2018

  1. Coumarin derivatives as promising xanthine oxidase inhibitors

    International Journal of Biological Macromolecules, Vol. 120, pp. 1286-1293

  2. Evaluation of trypanocidal and antioxidant activities of a selected series of 3-amidocoumarins

    Medicinal Chemistry, Vol. 14, Núm. 6, pp. 573-584

  3. Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer's disease

    Scientific Reports, Vol. 8, Núm. 1

  4. Targeting α -(1,4)-glucosidase in diabetes mellitus type 2: The role of new synthetic coumarins as potent inhibitors

    Current Topics in Medicinal Chemistry, Vol. 18, Núm. 27, pp. 2327-2337